Description: RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Home Page: www.relx.com
1-3 Strand
London,
WC2N 5JR
United Kingdom
Phone:
44 20 7166 5500
Officers
| Name | Title |
|---|---|
| Mr. Erik Engstrom | CEO & Exec. Director |
| Mr. Nicholas Lawrence Luff | CFO & Exec. Director |
| Ms. Kumsal Bayazit Besson | Chief Exec. Officer of Scientific, Technical & Medical |
| Mr. Colin Tennant | Head of Investor Relations |
| Mr. Henry Adam Udow | Chief Legal Officer & Company Sec. |
| Mr. Paul Abrahams | Head of Corp. Communications |
| Ms. Rosemary Thomson | Chief HR Officer |
| Mr. Mark Kelsey | Chief Exec. Officer of Risk |
| Ms. Jelena Sevo | Chief Strategy Officer |
| Mr. Michael Walsh | Chief Exec. Officer of Legal |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 20.3666 |
|---|---|
| Trailing PE: | 29.8958 |
| Price-to-Book MRQ: | 12.24 |
| Price-to-Sales TTM: | 6.9096 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 33000 |